Differences in the catalytic activity of the placental and gonadal isozymes of porcine aromatase cytochrome P450 (P450arom) were examined in cell lines exhibiting stable expression of recombinant enzyme. Cell lines were selected that expressed high, but similar, immunodetectable levels of each isozyme based on Western analysis. Aromatase activity varied with growth in culture, decreasing at confluence from a peak reached between 50 -80% cell density. Cells expressing the placental isozyme had 3-5 times higher catalytic activity (per mg protein) than those expressing the gonadal isozyme. The P450arom inhibitor fadrazole (1 M) inhibited more than 97% of this activity, whereas another imidazole, etomidate (1 M), selectively inhibited gonadal P450arom activity by 92%. Estrogen synthesis from androstenedione and testosterone was determined by RIA and confirmed by HPLC analysis, which also identified the accumulation of the 19-hydroxy and 19-oxo intermediates of the respective substrates.
3
H labeled at the C 1 and C 2 positions was stereo-selective for the ␤ orientation, but less so for testosterone than androstenedione during metabolism by the porcine placental (and human) isozyme than the gonadal isozyme. Testosterone showed a higher affinity for the porcine placental P450arom than the gonadal P450arom, but both isozymes had similar affinities for androstenedione. Testosterone was also aromatized more slowly than androstenedione by the porcine gonadal P450arom. These data suggest that catalytic differences have arisen in the substrate binding pocket during the evolution of isozymes of porcine P450arom that affect androgen metabolism, particularly the aromatization of testosterone. The physiological significance of these differences to the reproductive biology of the pig remains to be determined. (Endocrinology 140: [5202] [5203] [5204] [5205] [5206] [5207] [5208] [5209] [5210] 1999) A ROMATASE cytochrome P450 (P450arom) is the catalytic component of the aromatase enzyme complex responsible for the synthesis of estrogens from androgens. As such, this enzyme complex plays a unique role in maintaining a physiological balance between androgens and estrogen, which is critical for reproductive development and function in vertebrates. Furthermore, estrogen synthesis, through aromatase expression, contributes significantly to the normal growth and well-being of both males and females (1, 2) . Consistent with a fundamental contribution to reproduction and fertility, P450arom is highly conserved, demonstrating 50 -90% peptide sequence identity among mammalian, avian, and fish enzymes (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Despite the recent explosion of sequence information on the vertebrate aromatases, most of what is understood concerning the catalytic properties of this important enzyme has been derived from studies in human tissues, principally the placenta (15) , which expresses unusually high levels of activity compared with placentas of other primates or domestic animal species (16) . Much less is known concerning the functional biochemistry of P450arom expressed in other tissues or other species.
Aromatase cytochrome P450 is encoded by a single gene in humans, even though it is expressed in a broad array of tissues, including many that are steroidogenic in the classical sense as well as others generally considered nonsteroidogenic (15) . For instance, in addition to the placenta and the gonads of both men (17) and women (18) , P450arom is expressed in brain, liver (19) , adipose tissue (20) , and a number of tissues in the fetus (21) . Additionally, tumors from numerous sites, such as breast (22, 23) , gonads (24) , prostate (19) , and even myeloid leukemia cells (25) , have been shown to express P450arom. An elaborate mechanism involving alternative splicing of untranslated first exons and associated promoter elements differentially regulates tissue-specific expression in these sites (15) . The ovary is notable in this regard because it appears to be the only tissue expressing P450arom in which splicing is not invoked. Instead, the first untranslated exon is contiguous with exon II (26) . Hinshelwood et al. (27) showed that this characteristic of human ovarian P450arom expression is apparently shared in equine and porcine species, even at the nucleotide level. Moreover, this contrasts the lack of sequence conservation in the 5Ј-untranslated region among placental P450arom transcripts from these species (27) and even P450arom transcripts expressed in the porcine testis (28) . Thus, this feature of the basic structure of the CYP19 gene regulating P450arom expression appears conserved only in the female gonad. These observations are consistent with the suggestion that P450arom may have first evolved in the vertebrate ovary (15) and that expression in the placenta is a more recent event among eu-therian mammals. How the functional properties of P450arom might have changed to accommodate the physiological needs of the developing fetus in utero for both androgen metabolism and/or estrogen synthesis is an interesting, but unanswered, question.
As noted above, and in contrast to the wealth of information on human P450arom, many fewer studies have been conducted on the aromatase enzyme system of other mammals. Recent investigations in this laboratory and others have determined that there are essential differences in the biology of P450arom in the pig. Unlike any other mammal investigated to date, the pig expresses functionally distinct isozymes in a tissue-specific manner (12) . Evidence continues to accumulate that these are encoded by completely duplicated genes clustered on chromosome 1 (29 -31) . Our studies have shown that, unlike other mammals, a gonadal isozyme is expressed in the theca interna as well as the stratum granulosum of the ovarian follicle (32), the Leydig cell of the testes, and, interestingly, the zona reticularis of the adrenal gland of the pig (28) . The porcine placenta expresses a second isozyme (12, 29) , and a third is expressed in the early, preattachment porcine blastocyst (13) . However, the roles served by multiple isozymes of P450arom in the pig remain unclear and are difficult to elucidate given such a broad range of cellular environments possibly influencing catalytic function, in addition to other factors, including levels of expression. In fact, few studies conducted to date have compared the function of isozymes of P450arom; none has done so in the same cellular background or examined isozymes that have evolved in the same species. Kinetic experiments conducted on recombinant enzyme generated by transient transfection often suffer from low, unpredictable levels of expression. Therefore, the catalytic characteristics of the placental and gonadal isozymes of porcine P450arom were compared under conditions of stable recombinant expression in the hope of gaining insight into the evolution of function of this important enzyme system. The existence of gonadal and placental isozymes of porcine P450arom provides a unique opportunity to explore the functional evolution of a highly conserved enzyme critical for reproductive success in mammals. 
Materials and Methods Materials

Transient transfection
Experiments were conducted in which the parent 293 cell line was used for recombinant P450arom expression by transient transfection. Full-length complementary DNAs (cDNAs) were constructed in the pCMV expression plasmid. Conditions including levels of plasmid DNA (1.5 g), Lipofectamine (5 l), and time (6 h) were carefully optimized for 5 ϫ 10 5 cells cultured in six-well plates. Kinetic analyses of aromatase activity using androstenedione and testosterone were conducted 48 h posttransfection.
Establishment of cell lines exhibiting stable expression of porcine aromatases
Cultures of the human 293 fetal kidney cell line were maintained in DMEM high glucose with 10% FCS, 10 mm HEPES, and increasing concentrations (100 -800 g/ml) of geneticin (G418). All cells were killed at 600 g/ml during 6 days of culture. Both placental and gonadal porcine P450arom cDNAs were subcloned into the pcDNA3 vector (Invitrogen, Carlsbad, CA) containing the Neo R ORF gene. Transfection of 293 cells was carried out on 1 ϫ 10 6 cells using 30 l Lipofectamine and 5 g linearized plasmid DNA for 5 h. Cells were placed into medium without G418 for 48 h, after which time they were split 1:15 and transferred to selective medium containing 600 g/ml G418 thereafter. On day 14, individual colonies were lifted (24 for each transfection) using sterilized circles of Whatman filter paper (Clifton, NJ) soaked in trypsin solution and transferred to 24-well plates. Cells were grown and subcultured under the same, continuous antibiotic selection pressure until enough cells were obtained to cryopreserve aliquots of 2.5 ϫ 10 6 cells/ml, and separate lines expressing the gonadal and placental isozymes were stored. Each line was recovered from liquid nitrogen and cultured in G418 (600 g/ml) to verify viability. P450arom activities were determined at different stages of confluence and passage number by the tritiated water assay using [1␤- 3 H]androstenedione, as described below. Protein expression was further investigated by Western immunoblot analysis, also described below. All subsequent studies were conducted on lines designated G2 (gonadal P450arom isozyme) and P11 (placental P450arom isozyme).
Aromatase activity by tritiated water assay
Screening cells in monolayer culture for P450arom activity required measuring the incorporation of tritium into 3 H 2 O from [1␤-3 H]androstenedione. Incubations were carried out at 37 C in 5% CO 2 with 150 nm substrate (20% labeled, 80% radioinert) in duplicate wells. Incubation times varied from 30 min for the placental line to 2 h for the gonadal line. Inhibition of P450arom activity was achieved with the addition of fadrazole or etomidate (each at 1 m) to the culture medium along with the substrate. Reactions were stopped by the addition of 0.5 vol cold 30% trichloroacetic acid and were extracted with 2 vol chloroform. A portion of the aqueous phase was mixed with an equal volume of 5% charcoal-0.5% dextran suspension, centrifuged for 30 min at 2000 ϫ g, and quantified by liquid scintillation counting. Background values for 3 H 2 O released in the absence of cells were subtracted from each point. Substrate saturation and kinetic studies were carried out as described above from duplicate or triplicate wells using either [1␤- 3 
Estrone and 17␤-estradiol RIA
Estrogens were measured in culture medium without extraction using a double antibody system with 125 I-labeled estrone or estradiol tracers, enabling assays to be performed on samples containing 3 Hlabeled estrogens. Standard curves (0.2-500 pg/tube) for 17␤-estradiol and estrone were prepared in assay buffer and culture medium equivalent to the diluted sample medium, and antibody addition was adjusted to approximately 40% binding. Assays were sensitive to 1.0 and 0.2 pg for estrone and estradiol, respectively, and the intra-and interassay coefficients of variation were less than 10% and 15%, respectively, in each case.
Western immunoblot analysis
Cells were homogenized in PBS containing 1% sodium cholate and 0.1% SDS and sonicated for 3 sec. Equal amounts of protein (50 g) were subjected to SDS-PAGE (8% gel) in buffer containing 50 mm Tris, 383 mm glycine, 0.1% SDS, and 0.4 mm EDTA. Separated proteins were transferred by electroblot onto membranes and immunoblotted with antisera (1:1000) raised against recombinant human P450arom protein (courtesy of Dr. N. Harada, Fujita Health University, Aichi, Japan).
Steroid product analysis by HPLC
Medium from cell lines incubated with 7-3 H-labeled tracers were removed after 30 min to 2 h of culture. A mixture of authentic steroids (2.5 nmol each of testosterone, 19-hydroxytestosterone, 19-nortestosterone, estradiol, androstenedione, 19-hydroxyandrostenedione, 19-norandrostenedione, 19-oxoandrostenedione, and estrone) was added and equilibrated with each sample to facilitate extraction and to serve as standards during analysis. The steroids were extracted from the medium with a 10-fold volume of methylene chloride, and the organic phase was transferred and evaporated under reduced pressure. The steroidal residue was subjected to HPLC analysis (computer-controlled model HP1100 with photo diode array detector, Hewlett-Packard Co., Palo Alto, CA), and the radioactivity of the eluant was monitored by an in-line radioisotope detector (Ramona 2000, RayTest, New Castle, DE). The quarternary mobile phase was made up of water, methanol, acetonitrile, and tetrahydrofuran (solvents A-D, respectively) flowing at 1 ml/min. The column (4.6 ϫ 25 mm, 5-Ultrasphere ODS, Beckman Coulter, Inc., Fullerton, CA) was maintained at 30 C and initially equilibrated to 80% A, 10% B, 6% C, and 4% D. These conditions were maintained for the first 3 min of the gradient, after which the solvent composition changed linearly over 15 min to 63% A, 20% B, 11% C, and 6% D. Over the next 14 min, the solvent composition linearly changed to 45.5% A, 25.6% B, 15.9% C, and 13% D. The solvent system quickly (1 min) changed to 10% B, 83% C, and 4% D, and these conditions were held for an additional 2 min. The column was reequilibrated to the initial solvent conditions for 15 min before the next injection of sample.
Statistical analysis
Product formation was analyzed by linear regression. Kinetic constants were evaluated by ANOVA using the general linear models and Kruskal-Wallis nonparametric test procedures (SAS Institute, Inc., Cary, NC).
Results
Preliminary studies performed on the nonsteroidogenic human 293 kidney tumor cell line demonstrated that neither androstenedione nor testosterone was metabolized to any detectable degree over 6 h or more of culture. This suggested that the expression of other enzymes, such as 17␤-hydroxysteroid dehydrogenase, that might otherwise compete with P450arom for substrate was negligible in this cell line. Substrate affinities for both androstenedione and testosterone were estimated after transient transfection of expression plasmids in the parent 293 cells. Porcine placental P450arom exhibited a 3-fold lower K m for testosterone than for androstenedione (24 vs. 70 nm, respectively). Estimates of K m in transfections with the gonadal P450arom were problematic due to the low, variable levels of expression, slower rates of substrate metabolism, and correspondingly longer incubation times coupled with the higher background typical of the [1␤,2␤-3 H]testosterone label (33) . This being so, the K m estimates for androstenedione and testosterone were calculated at 50 and 68 nm, respectively.
Cell lines exhibiting stable expression of the porcine placental and gonadal isozymes of P450arom were developed to overcome the problems encountered with transient transfection, especially with the gonadal P450arom. Multiple independent cell lines expressing the gonadal (n ϭ 6) and placental (n ϭ 11) isozymes of porcine P450arom were isolated from 293 colonies under constant antibiotic selection pressure. Consistently, cells lines expressing the gonadal P450arom isozyme plated more efficiently, formed simple monolayers, and reached confluence earlier than lines expressing the placental isozyme. Cell lines expressing the placental P450arom isozyme not only grew more slowly, but also tended to grow in distinct clusters around the dish rather than as a more uniform monolayer. These growth characteristics were not seen to change in the presence of the P450arom inhibitor fadrazole (1 m). Lines were also screened for expression of P450arom by immunoblot analysis. Similar levels of immunodetectable P450arom were demonstrated in cell lines P11 and G2, expressing the placental and gonadal isozymes, respectively. The apparent molecular size was approximately 48 kDa, and no expression was observed in the nontransfected parent 293 cells (Fig. 1) .
Aromatase enzyme activity was further investigated in these cell lines by the release of tritiated water from [1␤-3 H]androstenedione, which was examined at different stages of confluence and after passage (Fig. 2) . Consistently higher activity was exhibited by the cell line expressing the placental isozyme than by that expressing the gonadal isozyme of porcine P450arom. Activity varied from 25-41 pmol/mg⅐2 h in the gonadal cell line and from 86 -239 pmol/mg⅐2 h in the placental cell line as confluence progressed from 40 -100% before and after passage (Fig. 2) . The lowest catalytic rates were observed when cells had reached 100% confluence, and all subsequent experiments were conducted on cells at a density of around 80% to maximize the yield of the recombinant P450arom. Greater than 97% of the aromatase activity was inhibited by fadrazole (1 m) addition in both cell lines. Gonadal P450arom activity was also inhibited by 92% in the presence of the other imidazole inhibitor, etomidate (1 m), which marginally inhibited placental P450arom activity by less than 10%.
The time course of conversion of both androstenedione and testosterone to estrone and estradiol was further evaluated by the tritiated water release assay and RIA of medium for each estrogen. Cells stably expressing porcine P450arom isozymes demonstrated progressive accumulation of estrogens with time, as shown in Fig. 3 . The rate of estrogen formation was generally greater from androstenedione than from testosterone and considerably faster for the placental P450arom than the gonadal isozyme, consistent with the results of activity analyses. Product formation was confirmed in parallel cultures by HPLC analysis, which demonstrated the presence of estrone, 19-oxoandrostenedione, and 19-hydroxyandrostenedione (Fig. 4) . Similarly, estradiol, 19-oxotestosterone, and 19-hydroxytestosterone were observed in cultures incubated with testosterone (data not shown). No evidence of other steroid products was noted either early (Ͻ10%) or late (Ͼ50%) in the metabolism of either of the substrates. These results also further confirmed the lack of interconversion of either androgen substrates or estrogen products by endogenous oxidoreductases during the course of these experiments.
The stereo-specific loss of hydrogen from the C 1 and C 2 positions during the aromatization of androstenedione and testosterone was examined using appropriately labeled substrates. Tritiated water formation was monitored during the metabolism of 1␤-3 H-, 1␤,2␤-3 H-, and 1␣,2␣-3 H-labeled steroids and expressed as a percentage of estrone and estradiol synthesis determined in medium by RIA after various times of incubation. An example is illustrated in Fig. 5 Cells from the P11 and G2 lines were cultured and passaged. Activity (picomoles per mg/2 h) was measured at different cell densities (percent confluence).
FIG. 3. Estrone (left panels)
and estradiol (right panels) formation from androstenedione and testosterone metabolism by the P11 (lower panels) and G2 (upper panels) cell lines expressing the placental and gonadal isozymes of porcine P450arom, respectively. Estrogen formation was measured by RIA of aliquots of medium removed at various times. Assays were performed in duplicate as described in Materials and Methods. The calculated linear regression coefficients are shown.
Kinetic studies were initiated by examining substrate vs. velocity relationships of the placental and gonadal isozymes with both substrates, and subsequent experiments used substrate concentrations below and above those that yielded approximately half the maximum velocity (V max ). Incubation times were chosen to limit substrate conversion to between 10 -30%. The results of these experiments were analyzed by double reciprocal plots (Fig. 6 ) from which apparent K m values were calculated ( Table 2 ). The K m for both substrates tended to be lower for the placental isozyme than for the gonadal isozyme and significantly lower (P Ͻ 0.05) for testosterone than for androstenedione metabolism by the porcine placental P450arom isozyme. There was little difference in V max for androstenedione and testosterone aromatization by the placental isozyme (244 and 198 pmol/mg⅐h), but a 3-fold higher V max was observed for the metabolism of androstenedione vs. testosterone for the gonadal isozyme (209 and 69 pmol/mg⅐h, respectively).
Discussion
These data document the establishment of cell lines stably expressing placental and gonadal isozymes of porcine P450arom that enable studies of substrate kinetics and stereospecific loss of hydrogen during aromatization. P450arom expression was verified by immunodetection of the expressed protein in cell lysates as well as by measurement of aromatase activity and estrogen formation, as confirmed by HPLC analysis. The levels of aromatase activities exhibited by each cell line were comparable to those measured in porcine placental and gonadal homogenates (12, 28) , although direct comparisons were not made by Western analysis. Evidence was presented for catalytic differences between these isozymes, which included sensitivity to inhibition by the imidazole etomidate, the stereo-specific loss of hydrogen from the C 1 and C 2 positions of testosterone, and apparent affinity constants for testosterone. Specifically, the gonadal isozyme, expressed in ovarian thecal and granulosa cells (12, 32, 34) , testes, and adrenal gland (28) of the pig, was inhibited by etomidate; the placental isozyme was not. A lower proportion of 3 H was released as 3 H 2 O during the metabolism of testosterone by the placental and human enzymes compared with the porcine gonadal P450arom isozyme. Finally, the placental isozyme of porcine P450arom exhibited a higher affinity for testosterone than the gonadal form of the enzyme. Collectively, these results demonstrate fundamental catalytic differences in androgen metabolism by isozymes of P450arom expressed in the placenta and gonads of the pig.
The possible existence of isozymes of P450arom in any species was first recognized in the pig by Corbin et al. (12) . Subsequent studies in this laboratory and others have confirmed the existence of multiple genes encoding the porcine P450arom isozymes (29 -31) . Although still a unique finding among mammals, at least two genes are also known to encode different isozymes of P450arom in the goldfish (14, 35) , a polyploid species. The results of the present study, con- Table 1 ) for each of the substrates and each P450arom isozyme.
sistent with the preliminary observations (12) , indicate that there are distinct functional differences between the placental and gonadal isozymes of porcine P450arom. Cell lines exhibiting stable expression of each isozyme, at similar levels based on immunoblot analysis, demonstrated slower aromatization of testosterone, particularly so for the gonadal isozyme, which, unlike the placental P450arom, was also susceptible to inhibition by etomidate (12) . The differential sensitivity to inhibition by etomidate, generally considered an inhibitor of 11␤-hydroxylase cytochrome P450, is consistent with functionally important, structural variations in the substrate binding pockets of the placental and gonadal isozymes. Product analysis verified the formation of intermediates (19-hydroxy-and 19-oxoandrogens), apparently released from the catalytic site during oxidation before estrogen formation. Earlier studies of aromatase with porcine ovarian microsomes (36, 37) as well as others studying human, rat, and equine aromatases (38 -40) demonstrated a significant release of intermediates. No evidence was found for the formation of 19-norandrostenedione or 19-nortestosterone, even though both steroids are resolved by the HPLC system that was developed and used in the current studies. This contrasts the results of Khalil et al. (41, 42) , but is consistent with the report by Garrett et al. (43) ; both investigators used porcine granulosa cells as the source of P450arom. Garrett et al. (43) suggested that nonenzymatic conversion during sample processing might explain the appearance of 19-norandrogens in medium from cultured porcine granulosa cells. If enzymatic synthesis does occur, the conditions for formation of 19-nor products were not reproduced in that or the present study.
The establishment of cell lines expressing the placental and gonadal isozymes of porcine P450arom also facilitated an examination of stereo-specific loss of hydrogen from the ␤ orientation of positions C 1 and C 2 on the steroid A ring of both androgen substrates. This forms the basis of the widely used radiometric procedure known as the tritiated water assay for aromatase activity (33) . The exact nature of the stereo-selective hydrogen loss, chemical or biological, remains unclear and largely unexplored in other species, except the rat (40) . The data presented here suggest that the tendency for selective loss of the ␤-oriented hydrogen from the C 1 and C 2 positions of androgen substrates differed for the placental and gonadal isozymes, particularly in the case of testosterone. Previous studies by Swinney et al. (40) suggested that the rate of release of ␤-hydrogen differed between rat ovarian and human placental P450arom enzymes. Specifically, less 3 androstenedione). However, based on P450arom isozymes expressed in the same cell background, the results of the present study suggest that the P450 itself, whether species or tissue derived, contributes to the observed differences in the rates of ␤-hydrogen loss. Thus, quantitative comparisons of aromatase activity among species at least, if determined by tritiated water release, should consider differential loss of label particularly if dual 1␤,2␤-3 H-labeled tracers are used. Our data suggest that the porcine placental isozyme is catalytically very similar to human P450arom, but that the gonadal isozyme is more distinct. These differences must involve important conformational changes in the substrate binding pocket of the gonadal isozyme that affect substrate Androstenedione (A 4 ) and testosterone (T 4 ) were labeled in either the ␣ or ␤ configurations at the C1 or C2 position of the steroid A ring as shown. Percentages shown for estrogen and water represent the means (n ϭ 5-7 determinations) of estimates that were calculated from the ratios derived at each time point for each P450arom/substrate combination (see Fig. 5 ).
orientation causing a tighter fit of the steroid in the active site. Graham-Lorence et al. (44) hypothesized that hydrogen abstraction and enolization occurred via a proton shuttle mechanism involving aspartate 309, a highly conserved, acidic residue that in structurally determined P450s projects into the pocket. This residue was predicted to lie within 2A of the substrate C 1 and C 2 . The stereo-specific loss of tritium from [1␤-3 H]androstenedione seen for both porcine isozymes and human and rat P450arom (40) suggest that this substrate is probably oriented with the ␤ face more exposed to the proton acceptor. The less selective loss of tritium during aromatization of [1␤, 2␤-3 H]testosterone suggests that this substrate must be slightly rotated relative to the proton acceptor, exposing the ␣ and ␤ labels more equally. The stereo-selectivity shown with the ␣-labeled substrates is consistent with the preferential removal of hydrogen, which has a higher zero point energy than tritium. Whether the characteristics of the stereo-selective loss of hydrogen during aromatization correlates with other aspects of catalytic activity of different isozymes of P450arom remains an interesting question. However, it seems from these data and those reported by Swinney et al. (40) that hydrogen abstraction and enolization of androstenedione in both isozymes and of testosterone in the gonadal isozyme are protein-facilitated reactions. Moreover, these reactions might not necessarily proceed in the same way for androstenedione and testosterone because of differences in orientation in the substrate binding pocket that depend on the species-or tissue-specific form of the P450arom in question.
Catalytic differences between the porcine placental and gonadal P450arom isozymes were also examined in kinetic experiments to estimate affinities for the C 19 steroid substrates androstenedione and testosterone. Similar K m estimates were obtained by transient transfection and in stable expressing cell lines for androstenedione and testosterone in the case of the placental isozyme. Stable expression was necessary to obtain reliable estimates of K m for testosterone metabolism by the gonadal P450arom. Collectively, these data indicate that the two isozymes have similar affinities for androstenedione, but that the gonadal isozyme has a significantly lower affinity for testosterone than the placental P450arom. The apparent K m for androstenedione (77 and 104 nm for placental and gonadal isozymes, respectively) is in the range reported for human P450arom by numerous researchers (3, 40, (45) (46) (47) . Apparent K m values reported for testosterone are more variable, sometimes similar to those for androstenedione (3, 47) , slightly higher (46), or markedly higher (45) , which may reflect different sources of enzymes or methods of purification. Our results suggest that there are functional differences in affinity for testosterone between the porcine placental and gonadal isozymes (33 vs. 116 nm, respectively) stably expressed in 293 cells, which, in the case of the placental isozyme, is also less than half the K m for androstenedione (77 nm). and for the recombinant enzyme expressed in vitro. Although the microsomal or in vitro environment may influence P450 activity (46) , the differences noted between the porcine isozymes examined here are unlikely to suffer from such potential confounding factors.
The results of the present study also indicated that testosterone was aromatized more slowly than androstenedione, as suggested by the slower accumulation of estradiol and by estimates of the apparent V max from kinetic experiments. However, a valid comparison of catalytic rates depends directly on equal levels of P450arom expression in each cell line, which our data suggest may change with the stage of confluence. Although immunoblot analysis suggested that levels were generally similar in each cell line, this also assumes that the antiserum used recognizes the isozymes with equal affinity. In fact, Hinshelwood et al. (9) considered that a single amino acid change rendered bovine P450arom essentially undetectable by immunoblot analysis, consistent with the possibility that small changes in structure might have marked effects on epitope recognition. For this reason, we recently overexpressed each porcine isozyme in insect cells using a baculovirus vector. This has enabled estimates to be made of P450arom content in preparations of both isozymes by difference spectroscopy and analysis of androgen metabolism on an equal molar basis. Complete kinetic experiments using these preparations are in progress. However, preliminary results confirm that the placental isozyme of porcine P450arom is 3 times as active in aromatizing androgen as the gonadal isozyme and is more efficient in doing so at lower testosterone concentrations (Corbin, C. J., and A. J. Conley, unpublished observations). These data compare well with the 3-to 5-fold differences in catalytic rates observed in the stable cell lines, suggesting that P450arom expressions in cell lines are similar, but that differences in activity arise from the catalytic characteristics inherent in the P450 isozymes they express. It also suggests that there are no major differences in immunorecognition by the antisera used for immunoblot analysis. Collectively, the data suggest that the greatest differences in catalytic function between the porcine gonadal and placental P450arom isozymes relate to their metabolism of testosterone. Moreover, despite the potential for differences arising from expression levels, variations with confluence or peculiarities arising during the development of the cell lines specifically investigated, the evidence points strongly to P450arom isozymes themselves as the source of the functional divergence reported here.
Based on the data presented above, we conclude that the evolution of porcine P450arom expression in the placenta was associated with an increase in the efficiency of androgen metabolism, potentially involving both the affinity and rate of aromatization. These changes are consistent with the lower androgen concentrations likely to be presented to the enzyme expressed in utero compared with P450arom in the ovarian follicle (32, 48, 49) . The apparent K m values typical of mammalian aromatases are considerably lower than those commonly reported for other steroid hydroxylases such as P450c17 (50) , suggesting that P450arom may be adapted for expression in cells or tissues not also synthesizing androgen substrates (51) . Equally, the greater affinity for testosterone may have important adaptive significance in terms of the physiological protection of female fetuses developing adjacent to males during sexual differentiation. It is perhaps noteworthy that there was no significant effect of the proximity of male fetuses on the development of females in pigs (52) , whereas an effect is obvious in rodents (53), a species that lacks P450arom in the placenta (54) . In other words, the lack of placental P450arom may leave the female fetuses of some mammalian species susceptible to androgenization in utero, a concept consistent with the pseudohermaphroditism observed in women suffering congenital P450arom deficiency (55, 56) . The similarity between the porcine placental and human P450arom isozymes suggests that similar functional shifts to more efficient testosterone metabolism may have occurred in other species exhibiting placenta P450arom expression. In fact, the reported bovine CYP19 pseudogene (57) might represent the disappearance of an ancestral CYP19 gene encoding P450arom after evolution of expression in the bovine placenta (9) . Further studies comparing P450arom function across species will add to our understanding of the roles of androgens and estrogens in vertebrate development and reproduction. To what degree this involves essential changes in regions of the P450 mediating substrate binding, membrane anchoring, redox partner association, or other physical features remains to be determined. 
